YW

Yi Wang

AP Araxes Pharma: 6 patents #8 of 17Top 50%
KO Kura Oncology: 5 patents #13 of 29Top 45%
University of Michigan: 4 patents #497 of 4,352Top 15%
Overall (All Time): #442,195 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer Liansheng Li, Jun Feng, Tao Wu, Yuan Liu, Alana K. BORUM +2 more 2024-11-05
11944627 Methods for treating hematological malignancies and Ewing's sarcoma Francis Burrows, Linda V. KESSLER, Liansheng Li, Pingda Ren, Tao Wu +1 more 2024-04-02
11673898 Substituted inhibitors of menin-MLL and methods of use Tao Wu, Liansheng Li, Pingda Ren, Jolanta Grembecka, Tomasz Cierpicki +3 more 2023-06-13
11639346 Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS Liansheng Li, Jun Feng, Tao Wu, Yuan Liu, Pingda Ren +1 more 2023-05-02
11555041 Bridged bicyclic inhibitors of menin-MLL and methods of use Tao Wu, Liansheng Li, Pingda Ren, Jolanta Grembecka, Tomasz Cierpicki +3 more 2023-01-17
11377441 Covalent inhibitors of KRAS Liansheng Li, Jun Feng, Tao Wu, Yuan Liu, Pingda Ren +1 more 2022-07-05
10781218 Substituted inhibitors of menin-MLL and methods of use Tao Wu, Liansheng Li, Pingda Ren, Jolanta Grembecka, Tomasz Cierpicki +3 more 2020-09-22
10752639 Bridged bicyclic inhibitors of menin-MLL and methods of use Tao Wu, Liansheng Li, Pingda Ren, Jolanta Grembecka, Tomasz Cierpicki +3 more 2020-08-25
10745385 Covalent inhibitors of KRAS Liansheng Li, Jun Feng, Tao Wu, Yuan Liu, Pingda Ren +1 more 2020-08-18
10736897 Compounds and methods of use thereof for treatment of cancer Liansheng Li, Jun Feng, Tao Wu, Yuan Liu, Pingda Ren +1 more 2020-08-11
10377743 Inhibitors of RAS and methods of use thereof Liansheng Li, Jun Feng, Yuan Liu, Pingda Ren, Yi Liu +1 more 2019-08-13